Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute bronchitis therapy with ivy leaf extracts: Hedelix vs Prospan
2007-003272-19Phase 3Completed
- Sponsor
- Krewel Meuselbach
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prospan in acute bronchitis (2 arms), sponsored by Krewel Meuselbach. Primary endpoint: Bronchitis Severity Score (BSS). Started Dec 2007; status: completed.
02
Drugs
prospan
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on 2007-003272-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003272-19.